Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

See our complete portfolio of awards below.

View Funded Institutions
View Funded Investigators
Find Clinical Trials

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Francisco Audrey Parent Funding Opportunity Discovery Research Advancing next-generation models for the development of thymoregenerative medicines $2,500,000
California Institute of Technology Magdalena Zernicka-Goetz Funding Opportunity Discovery Research Spatiotemporal Control of Human Primordial Germ Cell Fate by the Embryonic Niche $2,425,796
Gladstone Institutes, J. David Christina Theodoris Funding Opportunity Discovery Research Temporal AI models for programming therapeutic cell state transitions $2,499,998
University of California, San Francisco Dr Diana Jean Laird Funding Opportunity Discovery Research Neurovascular control of follicle growth using stem-cell derived ovary assembloids $2,499,997
University of California, Berkeley Dr. Andreas Stahl Funding Opportunity Discovery Research Generating biological age in a stem cell-based complex disease model of osteoarthritis $2,499,999
The Regents of the University of California on behalf of its Riverside Campus Joshua Morgan Funding Opportunity Discovery Research Validating Safety and Efficacy of Extremeophile Stress Tolerance Transgenes in Stem Cells $2,499,999
University of Southern California Mohamed Abou-el-Enein Funding Opportunity Discovery Research Revealing the Mechanistic Architecture Governing CAR-T Cell Potency and Failure at Single-Cell Resolution $2,499,738
University of California, Los Angeles Kitai Kim Funding Opportunity Discovery Research Foundational Mapping of Splicing-Derived Neoantigen Recognition in Human Sarcoma Using Stem Cell-Enabled Immune Platforms $2,500,000
University of California, San Francisco Dr. Neel S Singhal M.D. Funding Opportunity Discovery Research Uncovering disease and cell-type-specific constraints on therapeutic delivery using a human CNS tissue discovery platform $2,500,000
University of California, Los Angeles Dr. Aya Barzelay Wollman Funding Opportunity Discovery Research Mapping Human Retinal Niches to Improve Stem-Cell Therapy for Geographic Atrophy $2,500,000
University of California, San Francisco James Bayrer Funding Opportunity Discovery Research Impact of Sex-Differences on Intestinal Stem Cell Function in Pediatric Inflammatory Bowel Disease $2,499,999
University of Southern California Dr. Lu Wang Funding Opportunity Discovery Research A precision organoid platform to investigate APOE4 dependent cerebrovascular impairments $2,500,000
University of California, San Francisco Tomasz Nowakowski Funding Opportunity Discovery Research Leveraging lessons from normal development to overcome barriers to efficient transplantation of stem cell derived cortical neurons. $2,500,000
University of California, San Diego Professor Alysson R Muotri Funding Opportunity Discovery Research Allelic Expression States as Determinants of Neurodevelopmental Disorder Risk $2,500,000
University of California, San Francisco Yin Shen PhD Funding Opportunity Discovery Research Systematic cell-type-resolved single-base resolution functional characterization of neurodevelopmental risk genes $2,500,000
University of California, San Francisco Katja Gabriele Weinacht Preclinical Stage Projects Therapeutic Restoration of Immune Function through iPSC-derived Human Thymic Epithelial Cells $12,999,871
Stanford University Dr. Katja Weinacht Preclinical Stage Projects Therapeutic Restoration of Immune Function through iPSC-derived Human Thymic Epithelial Cells $0
EVADE Therapeutics Sonja Schrepfer Preclinical Stage Projects Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes $12,480,000
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Disease Team Therapy Planning I Stem Cells Secreting GDNF for the Treatment of ALS $63,487
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 23 24 25 26 27 28 29 30 31 32 33